Does Tenet <a href="https://healthylife7.com/health-departments-respond-to-bad-tick-year/” title=”Health departments respond to bad tick year”>Healthcare (THC) Still Sit Below Fair Value Today?
Bailey Pemberton
Mon, 20 July 2026 at 2:37 am GMT+5:30
3 min read
- THC
-2.15%
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St
Tenet Healthcare stock has delivered a 172.1% total return over the past 5 years. Yet at around US$194.91, the broader valuation checks still point to the shares looking inexpensive relative to fundamentals
A 172.1% return over 5 years signals that Tenet Healthcare has already rewarded patient shareholders. Any current discount therefore needs to be weighed against the gains that are already on the table
Expectations around the company’s ability to sustain healthy margins and convert earnings into cash can support the current valuation. Any pressure on profitability or higher capital needs may quickly narrow the perceived discount
Tenet Healthcare screens as undervalued across the broader checks, with a high value score of 6 out of 6, which suggests the current price still sits below what many investors might consider a full valuation
The issue now is whether Tenet Healthcare’s strong multi year share price performance has already captured the upside that these valuation checks imply, or if there is still meaningful value left for new investors
Find out why Tenet Healthcare’s 11.3% return over the last year is lagging behind its peers
Does Tenet Healthcare Look Undervalued on Earnings?
The P/E ratio is a useful yardstick for Tenet Healthcare because it directly links what you pay for the stock to the earnings the company is already producing. Tenet Healthcare currently trades on a P/E of about 9.9x, compared with a Healthcare industry average of 26.0x and a peer average of 20.5x, which puts the stock at a clear discount to many other hospital and healthcare providers
A fair P/E multiple for Tenet Healthcare, based on its profile, comes out at about 19.0x. Set against the current 9.9x, that is a wide gap, suggesting the market is pricing the stock well below what this model implies for a business with these earnings, margins and risk characteristics. For investors focused on earnings based metrics, the current P/E leaves room for the valuation to move closer to that fair ratio if sentiment or expectations shift
On the P/E multiple alone, Tenet Healthcare stock appears undervalued relative to both its tailored fair ratio and the broader Healthcare industry
See what the numbers say about this price — find out in our valuation breakdown
The Tenet Healthcare Narrative: What Would Justify Today’s Price?
Simply Wall St Narratives for Tenet Healthcare pick up where the valuation checks leave off by spelling out what combinations of future growth, margins and earnings would need to play out for Tenet Healthcare’s stock to be worth materially more or less than it is today on the market. Instead of stopping at a single output from a model or ratio, these Narratives lay out the underlying assumptions so you can see what the number relies on and watch how those conditions change over time on the Community page.
